Cleared Traditional

K181905 - AXIOS Stent and Delivery System, AXIOS Stent and Electrocautery Enhanced Delivery System (FDA 510(k) Clearance)

Mar 2019
Decision
252d
Days
Class 2
Risk

K181905 is an FDA 510(k) clearance for the AXIOS Stent and Delivery System, AXIOS Stent and Electrocautery Enhanced Delivery System. This device is classified as a Pancreatic Stent, Covered, Metallic, Removable (Class II - Special Controls, product code PCU).

Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on March 25, 2019, 252 days after receiving the submission on July 16, 2018.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5015. To Facilitate Transmural Endoscopic Drainage Of Pancreatic Pseudocysts.

Submission Details

510(k) Number K181905 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 16, 2018
Decision Date March 25, 2019
Days to Decision 252 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code PCU — Pancreatic Stent, Covered, Metallic, Removable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5015
Definition To Facilitate Transmural Endoscopic Drainage Of Pancreatic Pseudocysts